市場調查報告書
商品編碼
1586362
碳 13 市場、規模、佔有率、趨勢、行業分析報告:按純度、按應用、按最終用戶、按地區 - 市場預測,2024-2032 年Carbon-13 Market Size, Share, Trends, Industry Analysis Report: By Purity (98%-99% and >99%), Application, End User, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2024 - 2032 |
根據Polaris Market Research的最新研究,到2032年,全球碳13市場規模預計將達到1.2572億美元。該研究報告提供了對當前市場動態的詳細洞察,並對未來市場成長進行了分析。
碳 13 市場的主要驅動力是核磁共振 (NMR) 光譜的使用不斷增加,這使得碳 13 對於分子結構的詳細分析至關重要。 NMR 光譜依賴原子核的磁性,而碳 13 具有核自旋特性,在提供有關分子結構、動力學、反應狀態和化學環境的詳細資訊方面特別有用。
除了 NMR 光譜之外,醫療保健產業也是碳 13 的主要成長領域。這種同位素越來越多地用於非侵入性診斷程序,例如呼氣測試,用於診斷各種胃腸道疾病,包括與消化性潰瘍和胃癌相關的幽門螺旋桿菌(H. pylori)感染。
製造流程的技術進步預計將隨著時間的推移降低成本,並使碳13更容易被更廣泛的用戶使用。同位素分離技術的創新和產能的擴大有可能緩解供應鏈限制並降低碳13的總成本。此外,不斷壯大的中產階級和不斷上漲的醫療保健成本可能會推動對先進診斷工具的需求,包括那些利用碳13的診斷工具。
由於有機合成和材料科學領域的應用不斷擴大,98%-99%的細分市場即使純度稍低,也能提供令人滿意的結果,在2023年佔據市場主導地位。
由於醫療基礎設施的擴張和成像能力的技術進步,磁振造影 (MRI) 領域預計將以最高的複合年增長率成長。此外,隨著人口老化,慢性病的盛行率不斷增加,也推動了對 MRI 等有效影像解決方案的需求。
由於先進研究機構和製藥公司的存在,北美在 2023 年佔據了碳 13 市場的主導地位。此外,由於對個人化醫療和先進診斷的日益重視,北美對碳 13 的需求正在增加。
由於人們更加關注快速工業化和醫療保健領域的進步,預計亞太市場未來幾年將以高複合年增長率擴張。此外,旨在加強醫療基礎設施的政府重大措施正在提振市場。
The global carbon-13 market size is expected to reach USD 125.72 million by 2032, according to a new study by Polaris Market Research. The report "Carbon-13 Market Size, Share, Trends, Industry Analysis Report: By Purity (98%-99% and >99%); Application; End-user; and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2024 - 2032." gives a detailed insight into current market dynamics and provides analysis on future market growth.
The primary driver of the carbon-13 market is the expanding use of nuclear magnetic resonance (NMR) spectroscopy, where Carbon-13 is essential for the detailed analysis of molecular structures. NMR spectroscopy relies on the magnetic properties of nuclei, and Carbon-13, with its nuclear spin properties, is particularly useful for providing detailed information about the structure, dynamics, reaction state, and chemical environment of molecules.
In addition to NMR spectroscopy, the healthcare sector is a major growth area for carbon-13. The isotope is increasingly used in non-invasive diagnostic procedures, such as breath tests, which are employed to diagnose various gastrointestinal disorders, including infections by Helicobacter pylori (H. pylori), which is linked to peptic ulcer disease and gastric cancer.
Technological advancements in production processes are expected to reduce costs over time, making carbon-13 more accessible to a broader range of users. Innovations in isotope separation techniques, as well as scaling up production capacities, may help alleviate some of the supply chain constraints and reduce the overall cost of carbon-13, thus expanding its market potential. Additionally, the expanding middle class and increasing healthcare spending are likely to boost the demand for advanced diagnostic tools, including those utilizing Carbon-13.
The 98%-99% segment dominated the market in 2023 due to the expansion of applications in organic synthesis and materials science, where slightly lower purity levels suffice while still providing satisfactory results.
The magnetic resonance imaging (MRI) segment is estimated to grow at the highest CAGR due to the expansion of healthcare infrastructure and technological advancements in imaging capabilities. Additionally, the rising prevalence of chronic diseases, alongside an aging population, significantly boosts the demand for effective imaging solutions such as MRI.
North America dominated the carbon-13 market in 2023 due to the presence of advanced research institutions and pharmaceutical companies. Furthermore, the increasing emphasis on personalized medicine and advanced diagnostics has bolstered demand for carbon-13 in North America.
The market in Asia Pacific is expected to expand at a high CAGR in the coming years owing to rapid industrialization and a growing emphasis on healthcare advancements. Additionally, significant government initiatives aimed at enhancing healthcare infrastructure are propelling the market.
The global key market players include China Isotope & Radiation Corporation, Merck KGaA, Shanghai Chemical Industry Research Institute Co., Ltd., Cambridge Isotope Laboratories, Inc., Trace Sciences International, ISOFLEX, MedChemExpress, BuyIsotope, Avanti Polar Lipids, and Qmx Laboratories Ltd.
Polaris Market Research has segmented the carbon-13 market report based on purity, application, end user, and region: